Next-Generation Cancer Immunotherapy Using Quantum Computing Selected for NEDO Demonstration Program
Tokyo - A joint research and development project titled "Development and Demonstration of a Computational and Evaluation Platform for Next-Generation Cancer Immunotherapy Using Quantum Computing Technology," undertaken by NEC Corporation (NEC), Taiho Pharmaceutical Co., Ltd....
Read more

















































